BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)
NCT00523328
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
72
Enrollment
INDUSTRY
Sponsor class
Stopped
Analysis of data from 104RA203 failed to meet primary endpoint.
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
BG9924
Sponsor
Biogen